Profile of Enterobacteria Resistant to Beta-Lactams
- PMID: 32679663
- PMCID: PMC7400480
- DOI: 10.3390/antibiotics9070410
Profile of Enterobacteria Resistant to Beta-Lactams
Abstract
A serious emerging problem worldwide is increased antimicrobial resistance. Acquisition of coding genes for evasion methods of antimicrobial drug mechanisms characterizes acquired resistance. This phenomenon has been observed in Enterobacteriaceae family. Treatment for bacterial infections is performed with antibiotics, of which the most used are beta-lactams. The aim of this study was to correlate antimicrobial resistance profiles in Enterobacteriaceae by phenotypic methods and molecular identification of 14 beta-lactamase coding genes. In this study, 70 exclusive isolates from Brazil were used, half of which were collected in veterinary clinics or hospitals Phenotypic methodologies were used and real-time PCR was the molecular methodology used, through the Sybr Green system. Regargding the results found in the tests it was observed that 74.28% were resistant to ampicillin, 62.85% were resistant to amoxicillin associated with clavalunate. The mechanism of resistance that presented the highest expression was ESBL (17.14%). The genes studied that were detected in a greater number of species were blaGIM and blaSIM (66.66% of the samples) and the one that was amplified in a smaller number of samples was blaVIM (16.66%). Therefore, high and worrying levels of antimicrobial resistance have been found in enterobacteria, and a way to minimize the accelerated emergence of their resistance includes developing or improving techniques that generate diagnoses with high efficiency and speed.
Keywords: antibiogram; antimicrobial resistance; enterobacterias; molecular diagnosis; β-lactams.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Mlaga K.D., Lotte R., Montaudié H., Rolain J.-M., Ruimy R. ‘Nissabacter archeti’ gen. nov., sp. nov., a new member of Enterobacteriaceae family, isolated from human sample at Archet 2 Hospital, Nice, France. New Microbes New Infect. 2017;17:81–83. doi: 10.1016/j.nmni.2017.02.001. - DOI - PMC - PubMed
-
- Winn W.C., Allen S.D., Janda W.M., Koneman S. Diagnóstico Microbiológico: Texto e Atlas colorido. Guanab. Koogan. 2008;16:1–1760.
-
- Coque T., Baqueiro F., Canton R. Increasing prevalence of ESBL- producing Enterobacteriaceae in Europe. Eurosurveillance. 2008;13:1–11. - PubMed
-
- Vega S., Dowzicky M.J. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial. Ann. Clin. Microbiol. Antimicrob. 2017;16:1–16. doi: 10.1186/s12941-017-0222-0. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
